Other infections specific to the perinatal period

P16_OTH_INFECTIONS_SPECIFIC_PERINA_PERIOD

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — P39 Cause of death: ICD-10 — P39 2 out of 7 registries used, show all original rules.	209
4. Check minimum number of events None	209
5. Include endpoints None	209
6. Filter based on genotype QC (FinnGen only)	201

Control definitions (FinnGen only)

Control exclude: P16_INFECTIONS_SPECIFIC_PERINA_PERIOD

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: P3
Name in latin: Alii infectiones temporis perinatalis specificae

NAME	P16_OTH_INFECTIONS_SPECIFIC_PERINA_PERIOD
CONTROL_EXCLUDE	P16_INFECTIONS_SPECIFIC_PERINA_PERIOD
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	P39
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	P39
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other infections specific to the perinatal period based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	15148	6214	8934
Only index persons	9358	3723	5635
Unadjusted period prevalence (%)
Whole population	0.22	0.18	0.25
Only index persons	0.18	0.14	0.22
Median age at first event (years)
Whole population	-	0.00	0.00
Only index persons	0.00	0.00	0.00

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	201	107	94
Unadjusted period prevalence (%)	0.04	0.04	0.04
Median age at first event (years)	0.00	0.00	0.00

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
209: Matched controls
2088

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

P39.9

ICD-10 Finland

Infection specific to the perinatal period, unspecified

+∞

199.2

158

P39.1

ICD-10 Finland

Neonatal conjunctivitis and dacryocystitis

+∞

26.6

P01.10

ICD-10 Finland

Fetus and newborn affected by premature rupture of membranes 1-7 days before delivery

31.3

15.5

P22.1

ICD-10 Finland

Transient tachypnoea of newborn

11.6

12.6

P36.90

ICD-10 Finland

Suspected bacterial sepsis of newborn

+∞

11.6

P39.4

ICD-10 Finland

Neonatal skin infection

+∞

11.6

P39.0

ICD-10 Finland

Neonatal infective mastitis

+∞

10.5

P07.3

ICD-10 Finland

Other preterm infants

3.4

6.1

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40761536) Microorganisms panel - Urine sediment

105

2.45

3.68

3.1

3.0

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

8.77

3.28

2.2

1.6

32.33

32.86

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

0.00

3.21

0.0

2.1

—

31.34

—

(3002179) Metamyelocytes/100 leukocytes in Blood

2.38

2.97

6.4

4.7

0.40

0.49

—

(3025159) Blasts/100 leukocytes in Blood

2.38

2.97

6.5

6.2

0.00

—

(3021440) Promyelocytes/100 leukocytes in Blood

2.30

2.77

6.4

6.1

0.00

0.03

—

(3019225) pH of Specimen

0.00

2.65

0.0

5.1

—

(3017181) Myelocytes/100 leukocytes in Blood

2.20

2.52

6.4

6.0

0.20

0.57

—

(3029937) Albumin [Presence] in Urine by Test strip

299

1.64

2.14

3.5

0.00

estimate

-0.00

108

(3023368) Bacteria identified in Blood by Culture

226

1.71

2.11

3.6

4.6

—

(3000492) Spirometry study

118

1.96

2.10

1.4

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

0.00

2.10

0.0

1.1

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

525

0.62

1.85

2.8

3.4

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

3.60

1.85

1.0

1.1

—

(3018418) pH of Serum or Plasma

293

1.59

1.84

3.5

3.4

7.39

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

4.24

1.83

1.0

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

3.91

1.72

1.0

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1.97

1.70

2.5

2.7

4.86

5.13

pmol/l

0.71

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

3.05

1.59

6.2

6.8

—

(3019230) Fractional oxyhemoglobin in Venous blood

2.48

1.55

18.8

14.8

71.13

71.92

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

0.00

1.53

0.0

5.8

—

92.95

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

0.00

1.51

0.0

1.4

—

(3021589) Normoblasts [#/volume] in Blood

106

894

1.37

1.47

9.5

11.4

0.00

e9/l

-0.00

677

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

425

1.43

1.44

3.3

3.0

—

(3044640) Blood type and Crossmatch panel - Blood

364

0.61

1.44

2.3

3.7

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

155

1395

1.43

10.1

11.7

3.88

3.89

mmol/l

0.15

150

1340

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

243

0.55

1.39

1.0

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

174

1609

1.48

1.30

9.6

10.4

21.27

22.44

mg/l

0.16

116

1046

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

767

0.73

1.29

1.6

1.8

0.31

2.34

u/ml

3.70

142

(3041096) Erythrocytes [Presence] in Urine by Automated

318

1.44

1.27

3.5

2.8

—

(3027315) Oxygen [Partial pressure] in Blood

2.44

1.25

1.7

4.8

8.55

9.15

kpa

—

(3013290) Carbon dioxide [Partial pressure] in Blood

2.44

1.25

1.7

4.8

5.63

4.85

kpa

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

154

1399

1.38

1.23

10.1

11.7

139.50

139.51

mmol/l

0.02

149

1353

(3007853) Bacteria identified in Skin by Aerobe culture

222

0.56

1.23

1.6

1.7

—

(3025941) Bacteria identified in Stool by Culture

1.88

1.22

1.5

1.3

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

143

1.60

1.17

2.2

2.3

6.99

5.67

u/l

0.45

100

(3016650) Hepatitis A virus Ab [Presence] in Serum

2.53

1.15

1.2

1.1

—

(3024928) Oxygen saturation in Venous blood

2.04

1.13

18.6

13.1

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

1.99

1.10

4.1

3.9

2.61

3.11

e9/l

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

1.99

1.10

4.4

43.00

50.32

—

(3026782) Osmolality of Urine

294

1.40

1.04

3.1

3.5

468.13

629.97

mosm/kgh2o

3.48

264

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

108

0.45

1.04

7.8

8.7

173.20

167.31

—

108

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

124

1366

0.77

1.03

4.5

3.7

2.10

1.96

mu/l

0.41

111

1283

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1.95

1.03

2.7

6.5

202.78

454.32

mg/l

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

304

0.66

1.03

2.2

3.6

—

(3026389) Candida sp identified in Specimen by Organism specific culture

0.00

0.98

0.0

1.1

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

0.00

0.98

0.0

1.4

—

(3022145) Colonoscopy Study observation

1.71

0.93

1.5

—

(3002385) Erythrocyte distribution width [Ratio]

165

1540

1.33

0.92

13.1

14.7

13.36

13.04

1.01

158

1507

(3003694) ABO and Rh group [Type] in Blood

494

0.74

0.91

1.8

1.5

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

130

0.52

0.91

6.7

8.8

96.14

94.35

—

130

(36660697) Celiac disease serology panel - Serum

305

0.69

0.88

1.3

1.2

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

121

1.53

0.85

1.8

1.4

508.55

63207967.16

pmol/l

0.50

106

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

1.84

0.79

1.2

2.4

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

0.00

0.79

0.0

6.0

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.79

0.0

1.1

—

(3016038) Potassium [Moles/volume] in Urine

0.00

0.78

0.0

1.9

—

39.96

—

(3000093) Morphology [Interpretation] in Blood Narrative

0.00

0.76

0.0

1.1

—

(3030467) Casts [#/volume] in Urine by Automated count

422

1.27

0.74

4.2

4.5

0.08

0.17

e6/l

1.07

325

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1.66

0.74

17.0

12.0

0.72

0.57

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

481

1.25

0.71

4.8

—

(4200892) Spirometry reversibility

1.56

0.70

1.5

—

(36304419) Bacteria [Presence] in Urine

426

1.26

0.69

4.4

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

169

1763

0.78

0.67

4.0

3.8

—

(3044290) Cell count panel - Cerebral spinal fluid

1.65

0.67

3.1

6.8

—

(3011897) Casein IgE Ab [Units/volume] in Serum

1.80

0.66

1.0

1.3

0.88

4.29

u/ml

—

(3002582) Erythrocytes [#/volume] in Urine

458

1.24

0.64

4.9

4.6

17.49

27.39

e6/l

0.45

361

(3013512) EKG study

193

1.33

0.61

2.2

2.4

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

0.00

0.60

0.0

1.3

—

21.40

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

0.00

0.60

0.0

1.3

—

29.50

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

0.00

0.60

0.0

1.3

—

115.55

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.00

0.60

0.0

1.1

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

0.00

0.60

0.0

1.2

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

0.00

0.59

0.0

1.7

—

7.21

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

767

0.83

0.59

2.3

4.5

22.83

25.17

u/l

0.38

741

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

0.00

0.58

0.0

3.3

—

6.09

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

177

1.34

0.57

1.2

8.80

14.04

iu/ml

—

(3035350) Ketones [Presence] in Urine by Test strip

620

1.19

0.54

3.6

3.3

0.00

estimate

-0.00

107

(3021601) Nitrite [Presence] in Urine by Test strip

620

1.19

0.54

5.1

4.7

0.00

estimate

-0.00

114

(3014111) Lactate [Moles/volume] in Serum or Plasma

135

1.36

0.53

16.1

12.2

1.24

1.32

mmol/l

0.16

128

(3000850) Epithelial cells [#/volume] in Urine

308

1.24

0.52

4.5

3.4

7.97

8.51

e6/l

0.08

278

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1.51

0.52

1.7

1.6

—

(3008898) HLA-B27 [Presence]

1.49

0.51

1.0

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

891

0.85

0.51

2.7

1.36

1.40

mmol/l

0.36

841

(3026361) Erythrocytes [#/volume] in Blood

190

1845

1.32

0.49

13.5

15.0

4.65

4.66

e12/l

0.11

174

1755

(3009261) Glucose [Presence] in Urine by Test strip

625

1.18

0.49

3.7

3.3

0.00

estimate

-0.00

109

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

293

1.23

0.48

5.2

8.2

1.06

1.24

mmol/l

0.14

208

(3042936) Bacteria identified in Isolate by Culture

153

0.70

0.48

2.1

1.8

—

(3023511) Choriogonadotropin [Units/volume] in Urine

117

0.67

0.47

1.3

1.4

—

(40768797) Stomach Pathology biopsy report

116

0.68

0.47

1.1

1.4

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1.47

0.47

1.1

1.4

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1.47

0.47

1.1

1.4

—

(3010813) Leukocytes [#/volume] in Blood

190

1847

1.30

0.47

13.5

15.0

6.85

6.61

e9/l

0.75

175

1756

(3000764) Benzodiazepines [Presence] in Urine

273

0.78

0.46

1.3

1.9

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

156

1489

1.18

0.46

7.4

8.6

23.37

24.76

u/l

0.48

146

1424

(3028300) Cannabinoids [Presence] in Urine

272

0.79

0.45

1.3

1.9

—

(3027008) Opiates [Presence] in Urine

272

0.79

0.45

1.3

1.9

—

(3027944) Amphetamines [Presence] in Urine

272

0.79

0.45

1.3

1.8

—

(3007461) Platelets [#/volume] in Blood

189

1839

1.28

0.43

13.6

15.1

269.20

268.14

e9/l

0.08

173

1754

(3050129) First trimester maternal screen panel - Serum or Plasma

0.64

0.43

1.5

1.3

—

(1616796) Gas panel - Central venous blood

1.63

0.43

2.8

5.5

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

0.63

0.43

2.3

2.2

—

89.28

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

0.63

0.43

2.3

2.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.42

0.42

3.0

1.6

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1.53

0.41

1.2

1.4

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

849

0.87

0.41

2.7

2.6

1.26

1.07

mmol/l

1.09

809

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

115

1219

0.87

0.41

4.3

3.3

14.39

14.33

pmol/l

0.10

102

1088

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

0.00

0.41

0.0

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

0.00

0.41

0.0

1.0

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

0.00

0.41

0.0

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

0.00

0.41

0.0

1.0

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

0.41

0.0

1.2

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.00

0.41

0.0

1.1

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

0.00

0.41

0.0

2.1

—

37562.50

—

(40768441) Liver Pathology biopsy report

0.00

0.41

0.0

1.9

—

(3007164) IgA [Mass/volume] in Serum or Plasma

686

0.86

0.41

1.5

1.7

1.68

1.63

g/l

0.13

360

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.00

0.41

0.0

1.2

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

308

1.20

0.41

1.6

1.4

101.59

100.00

pmol/l

0.07

161

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

1.48

0.40

1.0

1.6

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

0.00

0.40

0.0

1.2

—

86.39

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

213

0.78

0.39

1.3

1.9

—

(3042733) HLA Ab [Presence] in Serum

0.00

0.39

0.0

2.6

—

(40768804) Tissue Pathology biopsy report

320

0.82

0.39

1.4

1.6

—

(3009542) Hematocrit [Volume Fraction] of Blood

189

1843

1.26

0.39

14.2

15.5

39.92

40.10

0.19

181

1763

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1.36

0.38

2.6

2.3

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

180

1.25

0.37

1.8

2.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

189

0.78

0.36

1.5

1.2

—

(3016879) Cocaine [Presence] in Urine

253

0.81

0.35

1.3

1.9

—

(3018095) Leukocytes [#/volume] in Urine

554

1.14

0.34

5.7

5.2

67.68

62.38

e6/l

0.04

372

(3017732) Neutrophils [#/volume] in Blood

0.66

0.33

3.8

1.3

3.15

3.93

e9/l

—

(3022313) Gas panel - Capillary blood

258

1.19

0.33

4.9

8.1

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1.28

0.32

1.7

2.4

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

930

1.12

0.32

7.8

6.3

114.21

114.99

ml/min/173m2

0.11

584

(3001122) Ferritin [Mass/volume] in Serum or Plasma

797

0.89

0.32

4.5

3.5

75.57

51.37

ug/l

0.36

748

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

531

0.87

0.31

3.1

2.6

—

(3044889) 12 lead EKG panel

637

1.12

0.30

2.2

2.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

108

0.73

0.29

1.6

1.5

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

508

0.88

0.29

3.0

2.4

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.26

0.29

1.1

1.2

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

299

1.16

0.29

9.6

10.9

22.82

23.77

mmol/l

1.09

299

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

944

0.90

0.29

2.1

2.2

5.62

5.32

mmol/l

0.43

848

(3013707) Erythrocyte sedimentation rate by Westergren method

108

1024

1.11

0.29

4.7

4.6

8.73

6.72

mm/h

0.68

102

949

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

262

1.17

0.28

3.6

4.3

3.60

3.24

e6/l

0.07

156

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

140

1.23

0.28

1.9

2.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

791

0.90

0.28

3.5

2.9

36.80

36.59

mmol/mol

0.05

744

(3048929) Epstein Barr virus Ab [Presence] in Serum

265

1.15

0.25

1.4

1.7

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

256

1.15

0.24

3.6

4.2

0.54

0.76

e6/l

0.24

149

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

896

0.91

0.24

2.5

2.1

—

(3000991) Gas panel - Venous blood

295

1.14

0.24

7.5

12.8

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1.36

0.23

1.0

5.8

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

1.36

0.23

1.2

2.3

—

(4062490) Immunoglobulin typing, IgG

1.32

0.23

1.4

—

(1761868) Lipid panel - Serum or Plasma

286

1.14

0.23

2.7

1.7

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

0.75

0.23

2.1

2.2

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

667

1.10

0.22

9.6

11.3

1.22

mmol/l

0.04

607

(3002256) Pathology report gross observation

104

0.76

0.21

1.1

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

5.5

—

0.57

—

(3033882) Carnitine [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

2.4

—

34.70

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.2

—

28.91

—

(40757494) Bilirubin.total [Moles/volume] in Blood

0.00

0.21

0.0

2.1

—

(3000722) Carnitine free (C0) [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

2.4

—

27.00

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

0.00

0.21

0.0

4.4

—

254.90

—

(3005011) Chlamydia sp Ab [Titer] in Serum

0.00

0.21

0.0

1.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

0.00

0.21

0.0

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

0.00

0.21

0.0

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

0.00

0.21

0.0

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

0.00

0.21

0.0

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

0.00

0.21

0.0

1.4

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

0.00

0.21

0.0

2.0

—

49.64

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.3

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

0.00

0.21

0.0

1.4

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

0.00

0.21

0.0

2.5

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

145

1.19

0.21

1.8

2.0

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

0.00

0.21

0.0

1.4

—

63.17

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.7

—

285.69

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

2.6

—

18.70

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

0.00

0.21

0.0

1.0

—

84.00

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

0.00

0.21

0.0

2.0

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.00

0.21

0.0

1.9

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1.26

0.20

4.8

3.4

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

0.00

0.20

0.0

1.8

—

(3003338) MCHC [Mass/volume]

156

1595

0.91

0.20

11.6

13.9

335.33

335.31

g/l

0.01

156

1572

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1.23

0.20

1.7

2.4

—

(3015736) pH of Urine

534

1.09

0.19

3.4

3.1

6.29

6.11

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

128

1.18

0.18

1.7

1.4

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

121

0.82

0.18

1.0

1.9

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1.19

0.18

1.4

—

(3037467) Urinalysis macro (dipstick) panel - Urine

891

1.08

0.18

4.5

4.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

0.75

0.17

1.8

1.6

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

895

0.93

0.16

2.7

2.58

2.63

mmol/l

0.26

840

(3048689) Calprotectin [Mass/mass] in Stool

368

0.91

0.16

2.9

3.7

128.73

91.46

ug/g

0.42

284

(40761511) CBC panel - Blood by Automated count

163

1598

1.09

0.16

7.3

7.4

—

(3026008) Bacteria identified in Urine by Culture

352

1.10

0.16

2.8

2.3

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

0.78

0.16

1.0

1.1

—

8.80

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

0.79

0.16

1.0

1.2

—

(4035726) Immunohistochemistry procedure

0.77

0.16

1.0

1.9

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

323

1.10

0.15

12.4

13.0

25.03

25.08

mmol/l

0.04

323

(3013139) Helicobacter pylori Ag [Presence] in Stool

1.10

0.15

1.2

1.1

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

169

1.14

0.15

1.2

1.1

1.02

9.58

u/ml

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

481

1.08

0.14

4.8

8.0

12.52

12.63

umol/l

0.01

444

(3028707) Methadone [Presence] in Urine by Screen method

128

0.85

0.14

1.2

2.3

—

(3020961) Endomysium IgA Ab [Titer] in Serum

228

1.11

0.14

1.3

1.4

—

13.13

—

(3001604) Monocytes [#/volume] in Blood

970

0.94

0.13

8.2

9.7

0.58

0.54

e9/l

0.54

819

(3013115) Eosinophils [#/volume] in Blood

990

0.94

0.13

8.5

10.4

0.19

0.20

e9/l

0.16

852

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

364

0.92

0.13

2.0

1.7

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

152

1.13

0.12

1.4

1.5

—

(3006315) Basophils [#/volume] in Blood

968

0.95

0.12

8.2

9.7

0.04

0.03

e9/l

2.05

817

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

505

0.93

0.12

1.6

1.8

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

1.06

0.09

1.4

4.6

28.20

28.23

—

(3002032) Base excess in Venous blood by calculation

321

1.07

0.09

9.9

11.3

0.66

1.42

mmol/l

0.55

260

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1.13

0.09

1.3

1.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

144

0.90

0.09

1.7

1.4

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.07

0.08

1.3

1.2

—

(3014007) Fractional oxyhemoglobin in Arterial blood

1.03

0.08

11.7

14.5

97.40

95.14

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

0.81

0.08

1.2

1.3

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

347

0.94

0.08

2.8

2.3

—

(21494755) Public health laboratory ask at order entry panel

1.14

0.08

1.2

1.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

133

0.90

0.08

1.8

1.9

—

(3035637) Corticotropin [Mass/volume] in Plasma

1.07

0.07

1.3

1.6

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

0.85

0.07

1.1

1.3

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

324

1.06

0.07

10.0

11.2

5.96

5.93

kpa

0.07

310

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

118

1.11

0.07

1.9

2.0

—

(3037121) Protein [Mass/volume] in Urine

0.86

0.07

3.1

10.7

0.13

0.34

g/l

—

(40758558) Short blood count panel - Blood

536

0.96

0.06

6.0

10.7

—

(3019198) Lymphocytes [#/volume] in Blood

997

0.97

0.06

7.9

9.6

2.20

2.14

e9/l

0.27

865

(3019832) Treponema pallidum Ab [Presence] in Serum

316

1.05

0.06

2.4

1.8

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

863

1.03

0.05

6.2

5.4

116.27

117.42

u/l

0.05

808

(3011397) Hemoglobin [Presence] in Urine by Test strip

337

1.05

0.05

2.9

3.2

—

(3019150) Specific gravity of Urine by Refractometry

330

0.96

0.03

3.2

2.9

1.02

kg/l

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

104

1027

1.02

0.03

9.1

11.3

3.54

3.43

e9/l

0.20

868

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

300

1.04

0.03

2.5

2.1

—

(3022217) INR in Platelet poor plasma by Coagulation assay

329

0.97

0.02

2.7

5.1

1.16

1.12

inr

0.13

104

(3011288) Drugs identified in Urine by Screen method

188

0.95

0.02

1.2

2.4

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1.08

0.02

1.6

1.3

—

(3024354) Oxygen [Partial pressure] in Venous blood

312

1.03

0.01

10.1

10.9

5.27

4.97

kpa

0.40

299

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

412

1.02

0.01

2.7

3.8

2.62

2.70

mg/l

0.10

362

(46235355) HIV 1 and 2 tests - Meaningful Use set

517

0.98

0.01

2.7

2.1

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

263

1.03

0.01

1.9

1.6

—

(40760892) CBC W Ordered Manual Differential panel - Blood

902

1.01

0.01

9.2

9.9

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

234

1.03

0.00

2.9

5.4

0.51

1.44

mg/l

1.33

161

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

136

1.03

0.00

1.6

1.9

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

131

0.99

0.00

14.7

9.9

105.54

105.11

mmol/l

0.12

131

(3020779) Urea [Moles/volume] in Serum or Plasma

215

1.02

0.00

10.4

14.3

6.12

5.10

mmol/l

0.56

210

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

159

1.01

0.00

1.3

3.89

4.06

u/ml

0.01

113

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

168

1.01

0.00

2.8

3.2

2143.71

1350.32

ng/l

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

119

1.01

0.00

1.0

1.2

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

213

0.98

0.00

2.3

13.57

15.70

ng/l

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

110

1.00

0.00

1.1

1.3

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

123

0.97

0.00

1.3

1.4

—

(3000494) Fungus identified in Specimen by Culture

123

0.97

0.00

1.4

2.4

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

135

1.04

0.00

1.6

1.9

239.13

174.05

u/ml

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1.00

0.00

11.7

14.1

0.57

0.70

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1.01

0.00

1.6

1.9

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.98

0.00

5.2

12.7

—

425.46

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1.00

0.00

11.7

14.1

0.88

1.18

—

(3013931) Oligosaccharides [Presence] in Urine

0.00

-0.00

0.0

1.0

—

(3004616) Nuclear Ab [Presence] in Serum

0.00

-0.00

0.0

1.1

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

0.00

-0.00

0.0

6.9

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

0.00

-0.00

0.0

4.2

—

(3040893) Potassium [Moles/volume] in Capillary blood

0.00

-0.00

0.0

4.4

—

4.26

—

(3032773) Endomysium IgG Ab [Titer] in Serum

0.87

-0.00

1.0

1.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

0.93

-0.00

1.7

1.3

—

(3045788) Cell count panel - Pleural fluid

0.00

-0.00

0.0

1.3

—

(3049233) Organic acids panel - Urine

0.00

-0.00

0.0

1.1

—

(4146454) Self-monitoring of blood glucose

0.00

-0.00

0.0

4.2

—

(3002619) Bacteria identified in Specimen by Culture

0.00

-0.00

0.0

1.1

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

8.1

—

647.43

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.4

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

0.00

-0.00

0.0

1.1

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

25.40

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

0.00

-0.00

0.0

2.5

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

0.00

-0.00

0.0

1.6

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

255.47

—

(40760512) CD34 cells/100 cells in Bone marrow

0.00

-0.00

0.0

2.1

—

(40765096) Chromosome analysis panel by Banding

0.00

-0.00

0.0

1.1

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.84

-0.00

6.2

11.8

—

96.71

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

0.00

-0.00

0.0

1.2

—

1.42

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.4

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

0.89

-0.00

1.3

2.1

—

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.4

—

1.82

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

0.87

-0.00

1.2

1.4

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1.02

-0.00

11.4

13.7

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

0.00

-0.00

0.0

1.4

—

(3010838) Calcium [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

2.8

—

3.74

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

0.00

-0.00

0.0

2.4

—

(3032641) Amino acids panel - Urine

0.00

-0.00

0.0

1.2

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

0.00

-0.00

0.0

2.0

—

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3001186) Copper [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

20.62

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

-0.00

0.0

2.2

—

(3006245) CD3-CD19+ cells/100 cells in Blood

0.89

-0.00

1.4

4.9

22.60

16.52

—

(3029396) Erythrocyte agglutination [Presence] in Blood

0.00

-0.00

0.0

2.6

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

0.00

-0.00

0.0

5.0

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

1.02

-0.00

1.4

4.4

9.60

8.12

—

(1175426) CD3 cells/100 lymphocytes in Blood

1.02

-0.00

1.4

4.4

67.40

68.80

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

0.00

-0.00

0.0

4.4

—

(3006653) Thiamine [Moles/volume] in Blood

0.00

-0.00

0.0

1.2

—

107.60

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

0.00

-0.00

0.0

1.1

—

(3012565) Volume of 24 hour Urine

0.00

-0.00

0.0

1.4

—

2000.00

—

(3041354) Potassium [Moles/volume] in Venous blood

0.00

-0.00

0.0

2.5

—

3.52

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

0.00

-0.00

0.0

2.5

—

(3034426) Prothrombin time (PT)

0.00

-0.00

0.0

1.0

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

7.4

—

3.72

—

(3005570) Glucose [Moles/volume] in Urine

0.00

-0.00

0.0

1.4

—

(3035285) Chloride [Moles/volume] in Venous blood

0.00

-0.00

0.0

2.5

—

107.33

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

1.02

-0.00

1.4

4.4

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

803.71

—

(3013727) Leukocytes other/100 leukocytes in Blood

0.00

-0.00

0.0

12.4

—

46.36

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

0.00

-0.00

0.0

1.4

—

5.56

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

0.00

-0.00

0.0

13.7

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

0.00

-0.00

0.0

1.0

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.7

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

0.86

-0.00

13.6

14.5

24.00

24.05

mmol/l

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.88

-0.00

2.2

1.5

—

(40761535) Cells panel - Urine sediment

1.01

-0.00

2.0

4.1

—

Mortality – FinRegistry

↥

Association

Association between endpoint P16_OTH_INFECTIONS_SPECIFIC_PERINA_PERIOD and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have P16_OTH_INFECTIONS_SPECIFIC_PERINA_PERIOD.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: P16_OTH_INFECTIONS_SPECIFIC_PERINA_PERIOD – Other infections specific to the perinatal period

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other infections specific to the perinatal period

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints